Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications

Purpose To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Methods Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (...

Full description

Saved in:
Bibliographic Details
Published inInternational ophthalmology Vol. 43; no. 12; pp. 4585 - 4593
Main Authors Liu, Jiannan, Wang, Hao, Gu, Wei, Zhao, Tingting, Fan, Wenxue, Peng, Shaomin
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.12.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Methods Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits. Results There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3. Conclusion YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.
AbstractList Purpose To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Methods Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits. Results There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3. Conclusion YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.
To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits. There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3. YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.
To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.PURPOSETo evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.METHODSThirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.RESULTSThere were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.YAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.CONCLUSIONYAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.
PurposeTo evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.MethodsThirty-six New Zealand rabbits were divided as follows: Group 1000 (n = 12) treated with YAG laser of 1000 mJ (5 mJ × 200 shots), Group 2000 (n = 12) treated with YAG laser of 2000 mJ (5 mJ × 400 shots), Group 3000 (n = 12) treated with YAG laser of 3000 mJ (5 mJ × 600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)) were performed to examine the rabbits.ResultsThere were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1α and TNF-α increased at 12 h and decreased to baseline on day 3. Levels of IL-1β increased at 12 h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.ConclusionYAG laser vitreolysis is safe when the distance is more than 2 mm from ablation point to the lens and the retina, and the total energy is less than 2000 mJ for one treatment procedure.
Author Liu, Jiannan
Gu, Wei
Zhao, Tingting
Fan, Wenxue
Peng, Shaomin
Wang, Hao
Author_xml – sequence: 1
  givenname: Jiannan
  surname: Liu
  fullname: Liu, Jiannan
  organization: Department of Ophthalmology, Dongguan Aier Eye Hospital Affiliated to Jinan University
– sequence: 2
  givenname: Hao
  surname: Wang
  fullname: Wang, Hao
  organization: Department of Ophthalmology, Hebei Eye Hospital
– sequence: 3
  givenname: Wei
  surname: Gu
  fullname: Gu, Wei
  organization: Department of Ophthalmology, Beijing Aier-Intech Eye Hospital
– sequence: 4
  givenname: Tingting
  surname: Zhao
  fullname: Zhao, Tingting
  organization: Department of Ophthalmology, Harbin Aier Eye Hospital
– sequence: 5
  givenname: Wenxue
  surname: Fan
  fullname: Fan, Wenxue
  organization: Department of Ophthalmology, Harbin Aier Eye Hospital
– sequence: 6
  givenname: Shaomin
  surname: Peng
  fullname: Peng, Shaomin
  email: pengshaomin@csu.edu.cn
  organization: Aier School of Ophthalmology, Central South University, Department of Ophthalmology, Harbin Aier Eye Hospital, Aier Retina Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37665493$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv3SAQhVGUKM_-gSwqpG6ycTqAAbubKorykiJl0WbRFcXccUrka1ywr3T_fbhxmqRddIEA8c2Zw5wDst2HHgk5ZnDKAPTnxEDXvAAu8qpkVcAW2WdSi4IrAdvvznvkIKVHAKh1rXbJntBKybIW--TnN9viuKahpT_OrmhnE0a68mPE0K2TT7QNkfp-jDa4qbORjj6lCdMXans7E7l0CGkMA0Y7-hVSF5ZD512-hD4dkZ3Wdgk_vOyH5P7y4vv5dXF7d3VzfnZbuJKrsSixaoREp0umnON1LRoAK2S7sEqDXjQOLKqKLRqQspTAZNMyFG0phWykduKQfJ11h6lZ4sLhxnNnhuiXNq5NsN78_dL7X-YhrEweIi8FlFnh5EUhht_5i6NZ-uSw62yPYUqGVwoU01xCRj_9gz6GKeaBZKoGzhTXz9TH95ZevfyZfgb4DLgYUorYviIMzCZiM0dscsTmOWKzURVzUcpw_4Dxrfd_qp4AU0SqTQ
Cites_doi 10.1001/jamaophthalmol.2017.2477
10.1016/j.ajo.2011.01.005
10.1016/j.ajo.2014.10.006
10.5301/ejo.5000854
10.1016/j.ajo.2011.01.026
10.1038/sj.eye.6700026
10.3109/08820538.2010.518865
10.1111/j.1755-3768.2009.01682.x
10.1097/00006982-200202000-00001
10.1007/BF02143063
10.1016/j.ophtha.2020.10.026
10.1159/000477159
10.1007/s40123-021-00422-6
10.1111/ceo.13190
10.3109/02713688709034861
10.1097/IAE.0000000000000063
10.1136/bjophthalmol-2016-309005
10.3928/23258160-20181101-21
10.1001/jamaophthalmol.2017.2388
10.3928/23258160-20211014-02
10.1007/BF00417297
10.1177/11206721211008036
10.1097/IAE.0000000000000065
10.1007/s12325-020-01261-w
10.1136/bcr-2022-248937
10.1186/s12886-020-01428-7
10.1016/0167-5699(88)91200-5
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7QL
7T7
7TK
7U9
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1007/s10792-023-02858-0
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Technology Research Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2630
EndPage 4593
ExternalDocumentID PMC10724304
37665493
10_1007_s10792_023_02858_0
Genre Journal Article
GrantInformation_xml – fundername: Aier Eye Hospital Group
  grantid: AM1901D1
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40E
53G
5GY
5QI
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
ADHKG
AGQPQ
NPM
PJZUB
PPXIY
7QL
7T7
7TK
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c426t-4e8b35ec7416cc2993b00a35fda6707dbc0ae681db05545015bf1e3f4535b57c3
IEDL.DBID C6C
ISSN 1573-2630
0165-5701
IngestDate Thu Aug 21 18:37:56 EDT 2025
Fri Jul 11 11:07:14 EDT 2025
Fri Jul 25 19:52:06 EDT 2025
Mon Jul 21 06:01:08 EDT 2025
Tue Jul 01 01:24:42 EDT 2025
Fri Feb 21 02:40:57 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Vitreous opacities
YAG laser vitreolysis
Floaters ablation
Vitreous floaters
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-4e8b35ec7416cc2993b00a35fda6707dbc0ae681db05545015bf1e3f4535b57c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1007/s10792-023-02858-0
PMID 37665493
PQID 2902162750
PQPubID 37279
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10724304
proquest_miscellaneous_2860617250
proquest_journals_2902162750
pubmed_primary_37665493
crossref_primary_10_1007_s10792_023_02858_0
springer_journals_10_1007_s10792_023_02858_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationSubtitle The International Journal of Clinical Ophthalmology and Visual Sciences
PublicationTitle International ophthalmology
PublicationTitleAbbrev Int Ophthalmol
PublicationTitleAlternate Int Ophthalmol
PublicationYear 2023
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Schulz-Key, Carlsson, Crafoord (CR5) 2011; 89
Katsanos, Tsaldari, Gorgoli, Lalos, Asproudis (CR14) 2020; 37
Liu, Wang, Zhao (CR27) 2020; 20
Stites, Terr (CR30) 1991
Hahn, Schneider, Tabandeh, Wong, Emerson (CR20) 2017; 135
Fleisher, Ferrell, Mcgahan (CR31) 1992; 33
Huang, Weng, Chen, Chang (CR18) 2018; 49
Bergstrom, Czyz (CR3) 2018
Lin, Li, Zhang, Hui, Moutari, Pazo (CR13) 2022; 11
Koo, Haddock, Bhardwaj, Fortun (CR17) 2017; 101
Bhattacherjee, Henderson (CR33) 1987; 6
CR10
Noristani, Schultz, Dick (CR21) 2016; 26
CR32
Delaney, Oyinloye, Benjamin (CR28) 2002; 16
Freyler, Arnfelser, Weiss (CR29) 1976; 199
Little, Jack (CR26) 1986; 224
Rheaume, Vavvas (CR2) 2010; 25
Mason, Albert, Feist (CR7) 2014; 34
Shah, Heier (CR12) 2017; 135
de Vries, Faraj, Gerbrandy, Hulsman (CR25) 2022; 15
Wagle, Lim, Yap, Neelam, Au Eong (CR4) 2011; 152
Sebag, Yee, Wa (CR8) 2014; 34
Tan, Mura, Oberstein, Bijl (CR9) 2011; 151
O'Day, Cugley, Chen, Fabinyi (CR16) 2018; 46
Schulz-Key, Carlsson, Crafoord (CR6) 2015; 89
Cowan, Khine, Chopra, Fazio, Francis (CR15) 2015; 159
Shields, Cheng, Ruby, Williams, Wolfe (CR23) 2021; 52
Vandorselaer, Van De Velde, Tassignon (CR11) 2001; 280
Garcia, Orduna Magan, Alvarez-Peregrina, Villa-Collar, Sanchez-Tena (CR24) 2021
Shields, Cheng, Wolfe (CR22) 2021; 128
Sebag (CR1) 2002; 22
Sun, Lee, Chen (CR19) 2017; 8
DP Stites (2858_CR30) 1991
KH Huang (2858_CR18) 2018; 49
RA Shields (2858_CR22) 2021; 128
MA Rheaume (2858_CR2) 2010; 25
BG Garcia (2858_CR24) 2021
AM Wagle (2858_CR4) 2011; 152
X Liu (2858_CR27) 2020; 20
R Noristani (2858_CR21) 2016; 26
HS Tan (2858_CR9) 2011; 151
2858_CR10
2858_CR32
YM Delaney (2858_CR28) 2002; 16
J Sebag (2858_CR8) 2014; 34
IT Sun (2858_CR19) 2017; 8
RA Shields (2858_CR23) 2021; 52
R O'Day (2858_CR16) 2018; 46
T Vandorselaer (2858_CR11) 2001; 280
R Bergstrom (2858_CR3) 2018
EH Koo (2858_CR17) 2017; 101
S Schulz-Key (2858_CR5) 2011; 89
P Bhattacherjee (2858_CR33) 1987; 6
P Hahn (2858_CR20) 2017; 135
JO Mason (2858_CR7) 2014; 34
CP Shah (2858_CR12) 2017; 135
LN Fleisher (2858_CR31) 1992; 33
S Schulz-Key (2858_CR6) 2015; 89
J Sebag (2858_CR1) 2002; 22
A Katsanos (2858_CR14) 2020; 37
H Freyler (2858_CR29) 1976; 199
T Lin (2858_CR13) 2022; 11
LA Cowan (2858_CR15) 2015; 159
E de Vries (2858_CR25) 2022; 15
HL Little (2858_CR26) 1986; 224
References_xml – volume: 135
  start-page: 973
  year: 2017
  end-page: 976
  ident: CR20
  article-title: Reported complications following laser vitreolysis
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2017.2477
– volume: 151
  start-page: 995
  year: 2011
  end-page: 998
  ident: CR9
  article-title: Safety of vitrectomy for floaters
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.01.005
– volume: 159
  start-page: 138
  year: 2015
  end-page: 143
  ident: CR15
  article-title: Refractory open-angle glaucoma after neodymium–yttrium–aluminum–garnet laser lysis of vitreous floaters
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2014.10.006
– year: 1991
  ident: CR30
  publication-title: Basic Human Immunology
– volume: 26
  start-page: e149
  year: 2016
  end-page: e151
  ident: CR21
  article-title: Cataract formation after YAG laser vitreolysis: importance of femtosecond laser anterior capsulotomies in perforated posterior capsules
  publication-title: Eur J Ophthalmol
  doi: 10.5301/ejo.5000854
– volume: 152
  start-page: 60
  year: 2011
  end-page: 65-e1
  ident: CR4
  article-title: Utility values associated with vitreous floaters
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.01.026
– volume: 16
  start-page: 21
  year: 2002
  ident: CR28
  article-title: Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters
  publication-title: Eye
  doi: 10.1038/sj.eye.6700026
– volume: 25
  start-page: 295
  year: 2010
  end-page: 302
  ident: CR2
  article-title: Pharmacologic vitreolysis
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2010.518865
– ident: CR10
– volume: 89
  start-page: 159
  year: 2011
  end-page: 165
  ident: CR5
  article-title: Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2009.01682.x
– volume: 22
  start-page: 1
  year: 2002
  end-page: 3
  ident: CR1
  article-title: Is pharmacologic vitreolysis brewing?
  publication-title: Retina
  doi: 10.1097/00006982-200202000-00001
– volume: 224
  start-page: 240
  year: 1986
  end-page: 246
  ident: CR26
  article-title: Q-switched neodymium: YAG laser surgery of the vitreous
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF02143063
– volume: 89
  start-page: 159
  year: 2015
  end-page: 165
  ident: CR6
  article-title: Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2009.01682.x
– volume: 128
  start-page: 616
  year: 2021
  ident: CR22
  article-title: Iatrogenic vitreous hemorrhage, subretinal hemorrhage, and branch retinal vein occlusion after YAG laser vitreolysis for symptomatic vitreous floaters
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2020.10.026
– volume: 8
  start-page: 321
  year: 2017
  end-page: 325
  ident: CR19
  article-title: Rapid cataract progression after Nd:YAG vitreolysis for vitreous floaters: a case report and literature review
  publication-title: Case Rep Ophthalmol
  doi: 10.1159/000477159
– volume: 11
  start-page: 201
  year: 2022
  end-page: 214
  ident: CR13
  article-title: The efficacy and safety of YAG laser vitreolysis for symptomatic vitreous floaters of complete PVD or non-PVD
  publication-title: Ophthalmol Ther
  doi: 10.1007/s40123-021-00422-6
– volume: 46
  start-page: 956
  year: 2018
  end-page: 958
  ident: CR16
  article-title: Bilateral posterior capsule injury after Nd:YAG laser vitreolysis: unintended consequence of floaters treatment
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/ceo.13190
– volume: 6
  start-page: 929
  year: 1987
  end-page: 934
  ident: CR33
  article-title: Inflammatory responses to intraocularly injected interleukin 1
  publication-title: Curr Eye Res
  doi: 10.3109/02713688709034861
– volume: 34
  start-page: 1055
  year: 2014
  end-page: 1061
  ident: CR7
  article-title: Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters
  publication-title: Retina
  doi: 10.1097/IAE.0000000000000063
– volume: 101
  start-page: 709
  year: 2017
  end-page: 711
  ident: CR17
  article-title: Cataracts induced by neodymium–yttrium–aluminium–garnet laser lysis of vitreous floaters
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2016-309005
– volume: 49
  start-page: e214
  year: 2018
  end-page: e217
  ident: CR18
  article-title: Iatrogenic posterior lens capsule rupture and subsequent complications due to Nd:YAG laser vitreolysis for vitreous floaters: a case report
  publication-title: Ophthalmic Surg Lasers Imaging Retina
  doi: 10.3928/23258160-20181101-21
– year: 2018
  ident: CR3
  publication-title: Vitreous floaters
– volume: 135
  start-page: 918
  year: 2017
  end-page: 923
  ident: CR12
  article-title: YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2017.2388
– volume: 52
  start-page: 610
  year: 2021
  end-page: 613
  ident: CR23
  article-title: Retinal complications after yttrium–aluminum–garnet laser vitreolysis for vitreous floaters
  publication-title: Ophthal Surg Lasers Imaging Retina
  doi: 10.3928/23258160-20211014-02
– volume: 199
  start-page: 267
  year: 1976
  end-page: 275
  ident: CR29
  publication-title: Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
  doi: 10.1007/BF00417297
– volume: 33
  start-page: 2120
  year: 1992
  end-page: 2127
  ident: CR31
  article-title: Synergistic uveitic effects of tumor necrosis factor-alpha and interleukin-1 beta
  publication-title: Invest Ophthalmol Vis
– year: 2021
  ident: CR24
  article-title: Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters
  publication-title: Eur J Ophthalmol
  doi: 10.1177/11206721211008036
– volume: 280
  start-page: 15
  year: 2001
  end-page: 19
  ident: CR11
  article-title: Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters
  publication-title: Bull Soc Belge Ophtalmol
– volume: 34
  start-page: 1062
  year: 2014
  end-page: 1068
  ident: CR8
  article-title: Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile
  publication-title: Retina
  doi: 10.1097/IAE.0000000000000065
– ident: CR32
– volume: 37
  start-page: 1319
  year: 2020
  end-page: 1327
  ident: CR14
  article-title: Safety and efficacy of YAG laser vitreolysis for the treatment of vitreous floaters: an overview
  publication-title: Adv Ther
  doi: 10.1007/s12325-020-01261-w
– volume: 15
  start-page: e248937
  year: 2022
  ident: CR25
  article-title: Secondary open-angle glaucoma following YAG-laser vitreolysis
  publication-title: BMJ Case Rep
  doi: 10.1136/bcr-2022-248937
– volume: 20
  start-page: 157
  year: 2020
  ident: CR27
  article-title: Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-020-01428-7
– volume: 151
  start-page: 995
  year: 2011
  ident: 2858_CR9
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.01.005
– volume: 34
  start-page: 1055
  year: 2014
  ident: 2858_CR7
  publication-title: Retina
  doi: 10.1097/IAE.0000000000000063
– volume: 26
  start-page: e149
  year: 2016
  ident: 2858_CR21
  publication-title: Eur J Ophthalmol
  doi: 10.5301/ejo.5000854
– volume: 159
  start-page: 138
  year: 2015
  ident: 2858_CR15
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2014.10.006
– ident: 2858_CR32
  doi: 10.1016/0167-5699(88)91200-5
– volume: 52
  start-page: 610
  year: 2021
  ident: 2858_CR23
  publication-title: Ophthal Surg Lasers Imaging Retina
  doi: 10.3928/23258160-20211014-02
– volume: 280
  start-page: 15
  year: 2001
  ident: 2858_CR11
  publication-title: Bull Soc Belge Ophtalmol
– volume: 89
  start-page: 159
  year: 2011
  ident: 2858_CR5
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2009.01682.x
– volume: 135
  start-page: 973
  year: 2017
  ident: 2858_CR20
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2017.2477
– volume: 22
  start-page: 1
  year: 2002
  ident: 2858_CR1
  publication-title: Retina
  doi: 10.1097/00006982-200202000-00001
– volume: 16
  start-page: 21
  year: 2002
  ident: 2858_CR28
  publication-title: Eye
  doi: 10.1038/sj.eye.6700026
– volume: 20
  start-page: 157
  year: 2020
  ident: 2858_CR27
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-020-01428-7
– volume-title: Basic Human Immunology
  year: 1991
  ident: 2858_CR30
– volume: 37
  start-page: 1319
  year: 2020
  ident: 2858_CR14
  publication-title: Adv Ther
  doi: 10.1007/s12325-020-01261-w
– volume: 25
  start-page: 295
  year: 2010
  ident: 2858_CR2
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2010.518865
– ident: 2858_CR10
– year: 2021
  ident: 2858_CR24
  publication-title: Eur J Ophthalmol
  doi: 10.1177/11206721211008036
– volume: 152
  start-page: 60
  year: 2011
  ident: 2858_CR4
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.01.026
– volume: 199
  start-page: 267
  year: 1976
  ident: 2858_CR29
  publication-title: Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
  doi: 10.1007/BF00417297
– volume: 33
  start-page: 2120
  year: 1992
  ident: 2858_CR31
  publication-title: Invest Ophthalmol Vis
– volume: 6
  start-page: 929
  year: 1987
  ident: 2858_CR33
  publication-title: Curr Eye Res
  doi: 10.3109/02713688709034861
– volume-title: Vitreous floaters
  year: 2018
  ident: 2858_CR3
– volume: 89
  start-page: 159
  year: 2015
  ident: 2858_CR6
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2009.01682.x
– volume: 34
  start-page: 1062
  year: 2014
  ident: 2858_CR8
  publication-title: Retina
  doi: 10.1097/IAE.0000000000000065
– volume: 49
  start-page: e214
  year: 2018
  ident: 2858_CR18
  publication-title: Ophthalmic Surg Lasers Imaging Retina
  doi: 10.3928/23258160-20181101-21
– volume: 135
  start-page: 918
  year: 2017
  ident: 2858_CR12
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2017.2388
– volume: 101
  start-page: 709
  year: 2017
  ident: 2858_CR17
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2016-309005
– volume: 15
  start-page: e248937
  year: 2022
  ident: 2858_CR25
  publication-title: BMJ Case Rep
  doi: 10.1136/bcr-2022-248937
– volume: 8
  start-page: 321
  year: 2017
  ident: 2858_CR19
  publication-title: Case Rep Ophthalmol
  doi: 10.1159/000477159
– volume: 46
  start-page: 956
  year: 2018
  ident: 2858_CR16
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/ceo.13190
– volume: 11
  start-page: 201
  year: 2022
  ident: 2858_CR13
  publication-title: Ophthalmol Ther
  doi: 10.1007/s40123-021-00422-6
– volume: 128
  start-page: 616
  year: 2021
  ident: 2858_CR22
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2020.10.026
– volume: 224
  start-page: 240
  year: 1986
  ident: 2858_CR26
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF02143063
SSID ssj0009796
Score 2.3172674
Snippet Purpose To evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Methods Thirty-six New Zealand rabbits were divided...
To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues. Thirty-six New Zealand rabbits were divided as follows:...
PurposeTo evaluate the safety of yttrium–aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.MethodsThirty-six New Zealand rabbits were divided as...
To evaluate the safety of yttrium-aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.PURPOSETo evaluate the safety of yttrium-aluminum-garnet...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4585
SubjectTerms Ablation
Abnormalities
Aluminum
Aqueous humour
Complications
Cytokines
Eye
Eye lens
IL-1β
Inflammation
Interleukin 8
Interleukins
Intraocular pressure
Lasers
Leukocytes (neutrophilic)
Medicine
Medicine & Public Health
Ophthalmology
Optical Coherence Tomography
Original Paper
Postoperative
Rabbits
Safety
Semiconductor lasers
Tissue analysis
Transmission electron microscopy
Tumor necrosis factor-TNF
Tumor necrosis factor-α
YAG lasers
Yttrium
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZgSBMvCNiAwEBG2huzcGM7dnlBE2JMSONlm1SeMtu5iL4kpc2Q-PfcOW6rMsGzHdm-O_u--M7fMXYcqrYK4KaigWkjtFWtCNE7PAzjBKTXlVP0OPniW3V-rb_OzCxfuK1yWuX6TEwHddNHuiN_X07RGxGlrvy4-CmoahRFV3MJjfvsAVGXkVXbmd2S7tpUn4te7Ahj5SQ_mslP5yzlXZYUxXTGCbnrmO6gzbtJk39FTpNDOnvMHmUkyU9H1T9h96B7yvYvcqz8gN1c-haG37xv-ffTLxxRMiz5r_mwhD7RkHCEq3xOo_QpF5UPSQerD9xnohL6dEHEGwsY-cH5TgL6Ibs--3z16Vzkegoioh8ehAYXlIFIICxG9EMK95xXpm18ZaVtQpQeKgSwQSLIMAgUQjsB1WqjTDA2qmdsr-s7eMF4bKZQAsKvMjo9sTE0Tjk0hwa89bo1BXu3Fma9GGkz6i1BMom-RtHXSfS1LNjRWt513kKreqvwgr3dNKPxU0TDd9DfYh9XJQhGfZ6P6tkMhydnhT-_qmBuR3GbDkSsvdvSzX8kgm2cYKmV1AU7Wet4O69_L-Pl_5fxij2kWvVjLswR2xuWt_AaEc0Q3iSz_QO3FfTF
  priority: 102
  providerName: ProQuest
Title Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications
URI https://link.springer.com/article/10.1007/s10792-023-02858-0
https://www.ncbi.nlm.nih.gov/pubmed/37665493
https://www.proquest.com/docview/2902162750
https://www.proquest.com/docview/2860617250
https://pubmed.ncbi.nlm.nih.gov/PMC10724304
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7aBEovJenTbWK20FsrkLVP9WYbO6ElprQ1OCd1dzUivkjGUQr595mVZBsn6aEX7WFn2dXMPr5lZr4F-ORUoRyaNMoxzSOheRE5bw1thn6AsRXK8JCcfDFT53PxbSEXHU1OyIW5578PKW46xEcmwdtopInoen4oB1yHZxrGarwj2NWp6pJiHm-3f_A8QJMPgyLveUabA2d6BC86pMiGrWmP4QmWL-HZRecLfwV_ftkC61tWFexyeMYIBeOa_V3Wa6wamhFGcJQtQy9VE2vK6kbH11-Z7YhIQtNVINZYYcv_zfYCzF_DfDr5PT6PuvcSIk_nbB0JNI5L9AFkeU_nDKc1Zbkscqt0rHPnY4uKAKqLCURIAgKuGCAvhOTSSe35GzgoqxLfAfN5igkSvEq8EQPtXW64IXPnaLUVhezB540ys1VLi5HtCJCD6jNSfdaoPot7cLLRd9YtkessSQleBI5kqv64rabJHTwWtsTqhmSMaiBWkHnbmmfbHe2Mii63vAdmz3BbgUCcvV9TLq8aAm0aYCJ4LHrwZWPj3bj-_Rvv_0_8AzwPb9O3sS8ncFCvb_CUEEzt-vBUL3QfDofT0WgWyrPL7xMqR5PZj5_9ZmLTd54M7wC-7fJB
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIgEXVL4DBYwEJ4jwxnHsrVShCihb2u2FVlpOqe04Yi_JspuC-qf4jZ1xkl0tFdx6jhMnM-OZ58zMM8Brm5WZ9XoYF35YxKkSZWyd0egM3cBzk2ZaUHPy-DgbnaZfJ3KyAX_6Xhgqq-x9YnDURe3oH_n7ZIjRiCh1-YfZz5hOjaLsan-ERmsWh_7iN27ZFrsHn1C_b5Jk__PJx1HcnSoQO4xGTZx6bYX0jqCIc-iNBVqeEbIsTKa4KqzjxmcI4yzHUCsxXNpy4EWZSiGtVE7gc2_ATQy8nDZ7aqJWJL8qnAdGHUKxVHzQNel0rXqK6jwTyppqqWO-HgivoNurRZp_ZWpDANzfgrsdcmV7randgw1f3Ydb4y43_wDOvpnSNxesLtn3vS8MUbmfs1_TZu7rQHvCEB6zKc1Sh9pX1gSdL3aY6YhR6NYZEX3MfMtHztYK3h_C6bVI-hFsVnXlnwBzxdAnHuFe4nQ6UM4WWmg0v8IbZdJSRvC2F2Y-a2k68hUhM4k-R9HnQfQ5j2C7l3feLdlFvjKwCF4tL-NiowyKqXx9jmN0FiAfjXncqmc5HXrqDDfbIgK9prjlACLyXr9STX8EQm98wSQVPI3gXa_j1Xv9-zOe_v8zXsLt0cn4KD86OD58BncSsr1Qh7MNm8383D9HNNXYF8GEGZxd95q5BC9eMU0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NTpp4QRs_sw0wEjxBtDSOYxcJocFWNsaqCZg0njLbuYi-JF2bgfav8dft7CStygRve44T2-fz3efc3WeAlyYtUoNqEOY4yMNE8iI0VisyhraPkU5SxV1x8vEoPThNPp-JsxX409XCuLTKziZ6Q51X1v0j34kH5I0cpW60U7RpESd7w_eTi9DdIOUird11Go2KHOHVbzq-zd4d7tFav4rj4f73jwdhe8NAaMkz1WGCynCB1sESa8kyc9JCzUWR61RGMjc20pgSpDMRuV1BrtMUfeRFIrgwQlpO370Dq9Kdinqw-mF_dPJ1Qfkr_e1grl4oFDLqtyU7beGedFmfsYuhKqHCaNkt3sC6N1M2_4rbenc4XId7LY5lu43ibcAKlvdh7biN1D-A82-6wPqKVQX7sfuJEUbHKfs1rqdYeRIURmCZjV0vlc-EZbXXgNlbpluaFPfqxNF-TLBhJ2dL6e8P4fRWZP0IemVV4hNgNh9gjAT-YquSvrQmV1yRMuaopU4KEcDrTpjZpCHtyBb0zE70GYk-86LPogC2O3ln7QaeZQt1C-DF_DFtPRdP0SVWl9RGpR4AujaPm-WZd0d2O6WjNw9ALS3cvIGj9V5-Uo5_enpvGmCc8CgJ4E23xotx_Xsam_-fxnNYo_2SfTkcHW3B3dipnk_K2YZePb3EpwStavOs1WEG57e9ba4Bm8g26A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+YAG+laser+vitreolysis+for+intraocular+tissues%3A+analysis+of+postoperative+complications&rft.jtitle=International+ophthalmology&rft.au=Liu%2C+Jiannan&rft.au=Wang%2C+Hao&rft.au=Gu%2C+Wei&rft.au=Zhao%2C+Tingting&rft.date=2023-12-01&rft.issn=1573-2630&rft.eissn=1573-2630&rft.volume=43&rft.issue=12&rft.spage=4585&rft.epage=4593&rft_id=info:doi/10.1007%2Fs10792-023-02858-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10792_023_02858_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-2630&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-2630&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-2630&client=summon